

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1514, 2005-01, pp. : 7-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


By Smeraldi Enrico Delmonte Dario
Expert Opinion on Drug Safety, Vol. 12, Iss. 6, 2013-11 ,pp. :


Agomelatine for Bipolar Depression: A Chronotherapeutic Agent?
Current Psychopharmacology, Vol. 4, Iss. 2, 2016-02 ,pp. :


A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression
Drug Safety, Vol. 34, Iss. 9, 2011-09 ,pp. :

